IMS Health’s initial public offering looks to be set for early April. The Wall Street Journal reports that private equity firms are preparing their “road show to pitch investors on its shares.”
Journal sources say the public-then-private-to-be-public-again company is expected to bring in around $1 billion, which it will use to pay down debt. Expectations are that shares will sell for around $21, which would put the company’s value at close to $7 billion.
The Journal notes that hitting the $1 billion mark would mark “would make IMS the third-largest US listed IPO of 2014,” and that half of this year’s IPOs have been among healthcare-related companies.
